Canadian biotech AbCellera has joined forces with Eli Lilly to co-develop antibody products to prevent and treat COVID-19, the disease caused by the novel SARS-Cov-2 coronavirus.
With coronavirus now declared a pandemic by WHO, all eyes are on pharma and other healthcare companies to develop solutions – but the industry isn’t immune to workforce and economic threats